Abstract
The invention relates to 6,5 heterobicyclic ring derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use for the treatment of inflammatory conditions driven by STING activation, such as, but not confined to, SLE and geographic atrophy.
Original language | English |
---|---|
Patent number | WO/2019/158731 |
IPC | A61K 31/437 2006.1,A61K 31/4375 2006.1,A61K 31/519 2006.1,A61K 31/4365 2006.1,C07D 471/04 2006.1,C07D 498/04 2006.1,C07D 513/04 2006.1,A61P 29/00 2006.1,A61P 19/00 2006.1 |
Priority date | 16/08/19 |
Filing date | 15/02/19 |
Publication status | Published - 22 Aug 2019 |